$90.44 +0.24 (%) Express Scripts Holding Co - NASDAQ

May. 22, 2015 | 04:00 PM

Partner Headlines

  1. Horizon Pharma Up On Bullish Leerink Initiation

    IBD | May. 22, 2015 | 11:39AM EST
  2. CVS Health Buys Omnicare, Citing 'Long-Term' Benefits

    IBD | May. 21, 2015 | 18:05PM EST
  3. Drug 'super spending' soars

    IBD | May. 13, 2015 | 18:55PM EST
  4. 20 Questions With David Rolfe Part I

    GuruFocus | May. 8, 2015 | 19:30PM EST
  5. Addiction Care Provider AAC Eyes National Brand

    IBD | May. 8, 2015 | 17:34PM EST
  6. Medivation, Jazz Q1 Reports Miss; Regeneron Beats

    IBD | May. 7, 2015 | 18:43PM EST
  7. Regeneron Q1 Earnings Beat As Eylea Research Pays Off

    IBD | May. 7, 2015 | 11:22AM EST
  8. GoPro, Other Earnings Trigger Wild Price Swings

    IBD | Apr. 28, 2015 | 20:25PM EST
  9. EXPRESS SCRIPTS

    IBD | Apr. 28, 2015 | 19:11PM EST
  10. Express Scripts Posts In-Line Q1 Earnings, Issues Strong Forecast

    Benzinga | Apr. 28, 2015 | 17:09PM EST
  11. Stocks Stumble To Early Losses; IPG Photonics Jumps

    IBD | Apr. 28, 2015 | 10:42AM EST
  12. Why CVS Health And McKesson May Be Good Stock Picks

    IBD | Apr. 16, 2015 | 17:54PM EST
  13. UnitedHealth Profit Soars On ObamaCare, Optum

    IBD | Apr. 16, 2015 | 16:09PM EST
  14. UnitedHealth Up After Topping Views, Raising Outlook

    IBD | Apr. 16, 2015 | 09:24AM EST
  15. UnitedHealth Eyes Biggest Earnings Gain In Years

    IBD | Apr. 13, 2015 | 08:02AM EST
  16. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD | Mar. 3, 2015 | 17:22PM EST
  17. Horizon Pharma Soars On Q4 Beat, Guidance Raise

    IBD | Feb. 27, 2015 | 11:48AM EST
  18. Catamaran EPS Tops, But Stock Falls On Weak Guidance

    IBD | Feb. 26, 2015 | 11:59AM EST
  19. 10 Stocks You Should Be Watching Today

    Benzinga | Feb. 24, 2015 | 04:21AM EST
  20. EXPRESS SCRIPTS

    IBD | Feb. 23, 2015 | 18:33PM EST
  21. UPDATE: Express Scripts Tops Q4 Expectations, Shares Rise After Hours

    Benzinga | Feb. 23, 2015 | 17:25PM EST
  22. Nasdaq Stretches Win Streak To 9 Days

    IBD | Feb. 23, 2015 | 17:03PM EST
  23. Earnings Scheduled For February 23, 2015

    Benzinga | Feb. 23, 2015 | 05:03AM EST
  24. Must Watch Stocks for Today

    Benzinga | Feb. 23, 2015 | 04:01AM EST
  25. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD | Feb. 20, 2015 | 16:58PM EST
  26. Rolfe Adds One Company to Portfolio in Fourth Quarter

    GuruFocus | Feb. 18, 2015 | 18:25PM EST
  27. Analyzing Needham Growth Fund's Pick: Express Scripts (ESRX)

    GuruFocus | Feb. 13, 2015 | 16:01PM EST
  28. Analyzing Needham Growth Fund's Pick: CarMax (KMX)

    GuruFocus | Feb. 13, 2015 | 13:00PM EST
  29. Rite Aid Stock Soars, Steps Up Competition With CVS

    IBD | Feb. 11, 2015 | 17:50PM EST
  30. Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's Viekira Pak

    GuruFocus | Feb. 6, 2015 | 10:59AM EST
  31. Thornburg Value Fund Q4 2014 Commentary

    GuruFocus | Feb. 4, 2015 | 11:24AM EST
  32. Gilead Q4 Earnings Beat, But Price War Taking Toll

    IBD | Feb. 3, 2015 | 19:26PM EST
  33. Baird Remains Buyers Of Gilead Before Earnings Release

    Benzinga | Jan. 29, 2015 | 14:18PM EST
  34. Cramer Gives His Opinion On Whole Foods Market, Whiting Petroleum And Express Scripts

    Benzinga | Jan. 29, 2015 | 06:57AM EST
  35. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD | Jan. 28, 2015 | 13:45PM EST
  36. Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition?

    GuruFocus | Jan. 22, 2015 | 12:32PM EST
  37. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD | Jan. 21, 2015 | 12:55PM EST
  38. Why Drug Pricing Could Bring Volatility To The Biotech Sector This Year

    Benzinga | Jan. 20, 2015 | 16:21PM EST
  39. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD | Jan. 16, 2015 | 15:43PM EST
  40. What The Market's Reading: An Iraq Ramp-Up & Biotech Moves

    Benzinga | Jan. 15, 2015 | 11:14AM EST
  41. Steven Romick Buys 7 US and International Stocks in Q4

    GuruFocus | Jan. 13, 2015 | 19:10PM EST
  42. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  43. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  44. AbbVie Inc.'s Forthcoming Future Looks Optimistic

    GuruFocus | Jan. 13, 2015 | 14:55PM EST
  45. Amgen's Decline May Be Linked To Comments Of Express Script's CEO

    Benzinga | Jan. 13, 2015 | 13:18PM EST
  46. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  47. AbbVie Stock Down After Guidance, Downgrade

    IBD | Jan. 9, 2015 | 11:49AM EST
  48. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus | Jan. 6, 2015 | 12:22PM EST
  49. Hepatitis Drugs Vie For Share

    IBD | Jan. 5, 2015 | 18:44PM EST
  50. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD | Jan. 5, 2015 | 18:21PM EST
Trading Center